top of page
ENL Logo larger canvas size.png

Natural

Safe

Proven

Once Daily

Small Gel Cap

ENL Logo larger canvas size.png

ENL is the discounted Cash Pay Option for Prescription EnLyte
 

ENL is an FDA Regulated, Prescription-Strength Folate 
-Recommended by Providers Nationwide-

ENL is the Non-Prescription, Medical Food version of EnLyte, Developed to Provide a Safe and Effective Option for Patients with Depression and Common Symptoms related to ADHD.

ENL Contains Proven, Evidence-Based Ingredients to Help Manage Depression by Combining Coenzymes, Cofactors, and Omegas to Normalize and Balance Serotonin, Dopamine, and Norepinephrine (Brain Chemicals that Regulate Mood). 

ENL is a Natural Complement to Drug Stimulants for Managing ADHD and the Complete Symptom Complex.

ENL Helps with Overall Mood, Anxiety, Irritability, Apathy, Concentration, Motivation, Energy, and Sleep.

"Vitamin intake is not the problem, it's vitamin metabolism...how well we metabolize those vitamins to the active forms needed by the brain are what can put you at risk for various illnesses and now we have a way to circumvent all of those genetic variances"

Andrew Farah, MD , Chief of Psychiatry, High Point Division of UNC Healthcare

ENL is a prescription-strength, all-natural folate containing L-Methylfolate and other important active ingredients that have been clinically shown to improve depressive symptoms in patients with Major Depressive Disorder (MDD) and who also tested positive for an MTHFR polymorphism.

ENL goes to work fast.  Patients in a monotherapy study began seeing results in as little as 2 weeks and did not report any side effects greater than placebo.

ENL uses safe ingredients that are generally recognized as safe (GRAS) by the FDA.  ENL is manufactured under strict requirements established by the FDA and its ingredients are gluten free, dairy free, wheat free, sugar free, egg free, and contains no artificial colorants. 

75% 

IMPROVEMENT

% of clinical trial participants who improved on EnLyte (ENL)

42% 

REMISSION

% of clinical trial participants who achieved full remission on EnLyte (ENL)